Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8317611 | Clinical Biochemistry | 2013 | 5 Pages |
Abstract
PTX3 levels are elevated in NSTE-ACS. However, the prognostic information provided by PTX3 levels is limited and inferior compared to CRP. Our data, thus, do not support the measurement of PTX3 in patients with NSTE-ACS.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Kai M. Eggers, Paul W. Armstrong, Robert M. Califf, Nina Johnston, Maarten L. Simoons, Per Venge, Stefan K. James,